INNOVUS PHARMACEUTICALS, INC.: 10-Q filed 2018-11-14

Name: INNOVUS PHARMACEUTICALS, INC.: 10-Q filed 2018-11-14
Creator: INNOVUS PHARMACEUTICALS, INC.
License: https://creativecommons.org/licenses/by/4.0/

What INNOVUS PHARMACEUTICALS, INC. reported in its quarterly report filed 2018-11-14 (fiscal Q3 2018): 37 published measures, 90 facts as tagged in accession 0001437749-18-020819.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-11-14
Fiscal period: fiscal Q3 2018
Accession: 0001437749-18-020819 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All INNOVUS PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-09-30	9,503,434	USD
At 2017-12-31	9,030,906	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-09-30	8,645,265	USD
At 2017-12-31	8,127,963	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-09-30	858,169	USD
At 2017-12-31	902,943	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-2,449,938	USD	92
2018-01-01 to 2018-09-30	-6,119,058	USD	273
2017-07-01 to 2017-09-30	-1,328,657	USD	92
2017-01-01 to 2017-09-30	-5,008,494	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-5,587,887	USD	273
2017-01-01 to 2017-09-30	-1,546,527	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	176,064	USD	273
2017-01-01 to 2017-09-30	10,131	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	4,921,401	USD	273
2017-01-01 to 2017-09-30	2,041,784	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-195,362	USD	273
2017-01-01 to 2017-09-30	-10,131	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-09-30	-41,700,286	USD
At 2017-12-31	-35,639,837	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	3,200	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-09-30	206,425	USD
At 2017-12-31	62,454	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	356,058	USD	273
2017-01-01 to 2017-09-30	997,030	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-1,502,577	USD	92
2018-01-01 to 2018-09-30	-4,328,729	USD	273
2017-07-01 to 2017-09-30	-1,215,600	USD	92
2017-01-01 to 2017-09-30	-3,996,939	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-09-30	4,522,878	USD
At 2017-12-31	3,721,896	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	381,663	USD	92
2018-01-01 to 2018-09-30	949,533	USD	273
2017-07-01 to 2017-09-30	104,276	USD	92
2017-01-01 to 2017-09-30	771,885	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-09-30	6,156,256	USD
At 2017-12-31	5,145,629	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2018-09-30	952,576	USD
At 2017-12-31	952,576	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2018-09-30	3,800,674	USD
At 2017-12-31	4,273,099	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2018-09-30	356,347	USD
At 2017-12-31	68,259	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2018-09-30	2,198,045	USD
At 2017-12-31	1,725,698	USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	1,536,792	USD	92
2018-01-01 to 2018-09-30	3,739,837	USD	273
2017-07-01 to 2017-09-30	480,076	USD	92
2017-01-01 to 2017-09-30	1,329,131	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	59,201	USD	92
2018-01-01 to 2018-09-30	93,093	USD	273
2017-07-01 to 2017-09-30	8,736	USD	92
2017-01-01 to 2017-09-30	26,982	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-09-30	208,169,412	shares
At 2017-12-31	167,420,605	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2018-09-30	42,350,286	USD
At 2017-12-31	36,375,359	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2018-09-30	2,340,849	USD
At 2017-12-31	1,239,296	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2018-09-30	3,800,674	USD
At 2017-12-31	4,273,099	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-09-30	1,265,474	USD
At 2017-12-31	363,080	USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

Period	Value	Unit	Days
At 2018-09-30	95,372	USD
At 2017-12-31	24,690	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	2,023,030	USD	92
2018-01-01 to 2018-09-30	5,638,352	USD	273
2017-07-01 to 2017-09-30	1,321,001	USD	92
2017-01-01 to 2017-09-30	4,207,899	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	32,093	USD	273
2017-01-01 to 2017-09-30	8,258	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	157,475	USD	92
2018-01-01 to 2018-09-30	472,425	USD	273
2017-07-01 to 2017-09-30	157,477	USD	92
2017-01-01 to 2017-09-30	472,675	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	290	USD	92
2018-01-01 to 2018-09-30	665	USD	273
2017-07-01 to 2017-09-30	-4,800	USD	92
2017-01-01 to 2017-09-30	-5,622	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-947,361	USD	92
2018-01-01 to 2018-09-30	-1,790,329	USD	273
2017-07-01 to 2017-09-30	-113,057	USD	92
2017-01-01 to 2017-09-30	-1,008,355	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	4,519	USD	273
2017-01-01 to 2017-09-30	80,344	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	2,000	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	287,909	USD	273
2017-01-01 to 2017-09-30	-959	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	472,347	USD	273
2017-01-01 to 2017-09-30	40,199	USD	273

Inspect the source

Entity: INNOVUS PHARMACEUTICALS, INC. / CIK 0001411879
Captured: 2026-09-22 19:47 UTC
SEC response SHA-256: e77a101a672b8634c33f41442578c32e719835a043b28e20b379158f9e2f8bab

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411879.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))